LEP and obesity due to melanocortin 4 receptor deficiency: In addition, the results of relevant study revealed that except for controlling of autoimmune inflammation, celastrol has the potential of pharmacological treatment of obesity as leptin sensitizer in silico drug screening methods [53, 54].